Please Wait.....
Report
Cell Cryopreservation Market By Type (Cryopreservation media, Equipment), By Application (Stem cells, Oocytes cells, Sperm cells, Others), By End User (Pharmaceutical and biotechnology company, Research institute, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
Market Report I 2023-06-01 I 266 Pages I Allied Market Research
The cell cryopreservation market size was valued at $10.3billion in 2022, and is projected to reach $76.6 billion by 2032, growing at a CAGR of 22.2% from 2023 to 2032.. Cryopreservation involves the preservation of organelles, cells, tissues, or any other biological component by freezing them at very low temperatures (?80C to ?196C) and suspending their cellular metabolism, which preserves the cells for an indefinite amount of time. At low temperatures, biological and chemical reactions in living cells are dramatically reduced. Thus, cryopreservation plays a vital role in maintaining the integrity and functionality of cells, which make it suitable for biological research workflows. When water within cells freezes, ice formation can cause a solute imbalance and damage the cellular structure. Thus, the proper usage of techniques and a freezing medium containing the right cryoprotectants and additives can help researchers to maximize the post-thaw viability of cells for cell culture.
The growth of the global cell cryopreservation market is majorly driven by increase in infertility among women coupled with rise in number of egg freezing cycles. According to The Society for Assisted Reproductive Technology, it was reported that the egg freezing cycle increased by 31% from 2020 to 2021 in the U.S. In addition, rise in presence of biobanks is anticipated to drive the growth of the cell cryopreservation market. Biobanking has gained prominence due to its crucial role in facilitating biomedical research, drug discovery, and personalized medicine. According to the Biobank Resource Center, as of 2023, there are 340 registered biobanks, including both Canadian and international biobanks.
Moreover, according to the Journal of Biopreservation and Biobanking, in 2022, it was reported that the BBMRI directory listed 641 biobanks from 17 countries (as of February 12, 2021). With the advancement of biobanking technologies and the establishment of larger and more comprehensive biobanks, the demand for efficient and reliable cell cryopreservation methods has grown significantly. Furthermore, increase in R&D activities in pharmaceutical and biotechnology industries, rise in government support for R&D activities, and increase in prevalence of chronic diseases such as cancer and Parkinson's propel the growth of the market.
According to Health Resource and Service Administration, in 2023, it was reported that the donor registry contains more than 9 million potential donors in the U.S. Furthermore, as per the National Library of Medicine, in 2022, it was reported that various preclinical research activities are conducted in embryonic stem cells for the treatment of wide range of disease such as retinal diseases, Parkinson's disease, Huntington's disease, spinal cord injury, myocardial infarction, and type 1 diabetes. In addition, the Government of India conducted stem cell research through various departments and institutions by supporting basic as well as clinical research through national funding agencies such as the Indian Council of Medical Research (ICMR), Department of Biotechnology (DBT), and Department of Science and Technology (DST).
Furthermore, according to Regulatory Affairs Professionals Society, in 2021, there were around 2,754 clinics engaged in providing stem cell therapies. Consequently, the growing demand for stem cell therapies acts as a significant driver of the cell cryopreservation market. In addition, surge in demand for personalized medicines is expected to act as a significant driver of the cell cryopreservation market. Cell-based therapies, such as immune cell-based immunotherapies and engineered cell therapies, are being explored as personalized treatment approaches. Cryopreservation enables long-term storage of patient-specific cells, including immune cells, which can be used in the development of personalized therapies.
By preserving these cells, cryopreservation ensures their availability when needed for patient-specific treatments. As the interest in personalized medicine continues to grow, the demand for cell cryopreservation methods and storage facilities increases simultaneously, thereby augmenting the growth of the global market. Furthermore, rise in infertility rates notably contributes toward the growth of the market. However, availability of alternative therapies for cell cryopreservation and high maintenance cost in storage procedure hinder the growth of the market.
The global cell cryopreservation market is segmented into type, application, end user, and region. On the basis of type, the market is bifurcated into cryopreservation media and equipment. The cryopreservation media segment is further sub segmented into ethylene glycol, dimethyl sulfoxide, glycerol, and others.. The equipment segment is subsegmented into freezers, liquid nitrogen supply tanks, and others.
Depending on application, the market is classified into stem cells, oocytes cells, sperm cells, and others. By end user, it is segregated into pharmaceutical & biotechnology company, research institute, and others. Region wise, it is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). The major companies profiled in the report include Merck Group KGaA, HiMedia Laboratories, Thermo Fisher Scientific Inc. , Eppendorf Corporate, BioLife Solutions, Inc., Lonza, Sartorius AG, Creative Biolabs, Sartorius AG, and PromoCell GmbH.
Key Benefits For Stakeholders
-This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cell cryopreservation market analysis from 2021 to 2031 to identify the prevailing cell cryopreservation market opportunities.
-The market research is offered along with information related to key drivers, restraints, and opportunities.
-Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
-In-depth analysis of the cell cryopreservation market segmentation assists to determine the prevailing market opportunities.
-Major countries in each region are mapped according to their revenue contribution to the global market.
-Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
-The report includes the analysis of the regional as well as global cell cryopreservation market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
- Cryopreservation media
- Agent
- Ethylene glycol
- Dimethyl sulfoxide
- Glycerol
- Others
- Equipment
- Type
- Freezers
- Liquid nitrogen supply tanks
- Others
By Application
- Stem cells
- Oocytes cells
- Sperm cells
- Others
By End User
- Pharmaceutical and biotechnology company
- Research institute
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Malaysia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa,
- Saudi Arabia
- Rest of LAMEA
- Key Market Players
- BioLife Solutions, Inc.
- Creative Biolabs
- Danaher Corporation
- Eppendorf Corporate
- HiMedia Laboratories
- Lonza
- Merck Group KGaA
- PromoCell GmbH
- Sartorius AG
- Thermo Fisher Scientific Inc.
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter's five forces analysis
3.3.1. Low bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Low intensity of rivalry
3.3.5. Low bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in number of egg freezing cycles
3.4.1.2. Increase in research and development activities for stem cells
3.4.1.3. Rise in number of biobanks and surge in demand for personalized medicines
3.4.2. Restraints
3.4.2.1. Availability of alternative therapies for cell cryopreservation
3.4.3. Opportunities
3.4.3.1. Increase in government support for research and development activities
3.4.3.2. Rise in focus of manufacturers on developing novel products for preserving various cells
3.5. COVID-19 Impact Analysis on the market
3.6. Patent Landscape
CHAPTER 4: CELL CRYOPRESERVATION MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Cryopreservation media
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Cryopreservation media Cell Cryopreservation Market by Agent
4.3. Equipment
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.3.4. Equipment Cell Cryopreservation Market by Type
CHAPTER 5: CELL CRYOPRESERVATION MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Stem cells
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Oocytes cells
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Sperm cells
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Others
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: CELL CRYOPRESERVATION MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Pharmaceutical and biotechnology company
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Research institute
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: CELL CRYOPRESERVATION MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Type
7.2.3. Market size and forecast, by Application
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Type
7.2.5.1.3. Market size and forecast, by Application
7.2.5.1.4. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Type
7.2.5.2.3. Market size and forecast, by Application
7.2.5.2.4. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Type
7.2.5.3.3. Market size and forecast, by Application
7.2.5.3.4. Market size and forecast, by End User
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Type
7.3.3. Market size and forecast, by Application
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Type
7.3.5.1.3. Market size and forecast, by Application
7.3.5.1.4. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Type
7.3.5.2.3. Market size and forecast, by Application
7.3.5.2.4. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Type
7.3.5.3.3. Market size and forecast, by Application
7.3.5.3.4. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Type
7.3.5.4.3. Market size and forecast, by Application
7.3.5.4.4. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Type
7.3.5.5.3. Market size and forecast, by Application
7.3.5.5.4. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Type
7.3.5.6.3. Market size and forecast, by Application
7.3.5.6.4. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Type
7.4.3. Market size and forecast, by Application
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Type
7.4.5.1.3. Market size and forecast, by Application
7.4.5.1.4. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Type
7.4.5.2.3. Market size and forecast, by Application
7.4.5.2.4. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Type
7.4.5.3.3. Market size and forecast, by Application
7.4.5.3.4. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Type
7.4.5.4.3. Market size and forecast, by Application
7.4.5.4.4. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Type
7.4.5.5.3. Market size and forecast, by Application
7.4.5.5.4. Market size and forecast, by End User
7.4.5.6. Malaysia
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Type
7.4.5.6.3. Market size and forecast, by Application
7.4.5.6.4. Market size and forecast, by End User
7.4.5.7. Rest of Asia-Pacific
7.4.5.7.1. Key market trends, growth factors and opportunities
7.4.5.7.2. Market size and forecast, by Type
7.4.5.7.3. Market size and forecast, by Application
7.4.5.7.4. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Type
7.5.3. Market size and forecast, by Application
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Type
7.5.5.1.3. Market size and forecast, by Application
7.5.5.1.4. Market size and forecast, by End User
7.5.5.2. South Africa,
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Type
7.5.5.2.3. Market size and forecast, by Application
7.5.5.2.4. Market size and forecast, by End User
7.5.5.3. Saudi Arabia
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Type
7.5.5.3.3. Market size and forecast, by Application
7.5.5.3.4. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Type
7.5.5.4.3. Market size and forecast, by Application
7.5.5.4.4. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Creative Biolabs
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.2. Eppendorf Corporate
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. Lonza
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.4. PromoCell GmbH
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.5. Sartorius AG
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.6. BioLife Solutions, Inc.
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.6.7. Key strategic moves and developments
9.7. Danaher Corporation
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.7.7. Key strategic moves and developments
9.8. Thermo Fisher Scientific Inc.
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.8.7. Key strategic moves and developments
9.9. HiMedia Laboratories
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.10. Merck Group KGaA
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
LIST OF TABLES
TABLE 01. GLOBAL CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 02. CELL CRYOPRESERVATION MARKET FOR CRYOPRESERVATION MEDIA, BY REGION, 2022-2032 ($MILLION)
TABLE 03. GLOBAL CRYOPRESERVATION MEDIA CELL CRYOPRESERVATION MARKET, BY AGENT, 2022-2032 ($MILLION)
TABLE 04. CELL CRYOPRESERVATION MARKET FOR EQUIPMENT, BY REGION, 2022-2032 ($MILLION)
TABLE 05. GLOBAL EQUIPMENT CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 06. GLOBAL CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 07. CELL CRYOPRESERVATION MARKET FOR STEM CELLS, BY REGION, 2022-2032 ($MILLION)
TABLE 08. CELL CRYOPRESERVATION MARKET FOR OOCYTES CELLS, BY REGION, 2022-2032 ($MILLION)
TABLE 09. CELL CRYOPRESERVATION MARKET FOR SPERM CELLS, BY REGION, 2022-2032 ($MILLION)
TABLE 10. CELL CRYOPRESERVATION MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 11. GLOBAL CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 12. CELL CRYOPRESERVATION MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY, BY REGION, 2022-2032 ($MILLION)
TABLE 13. CELL CRYOPRESERVATION MARKET FOR RESEARCH INSTITUTE, BY REGION, 2022-2032 ($MILLION)
TABLE 14. CELL CRYOPRESERVATION MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 15. CELL CRYOPRESERVATION MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 16. NORTH AMERICA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 17. NORTH AMERICA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 18. NORTH AMERICA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 19. NORTH AMERICA CELL CRYOPRESERVATION MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 20. U.S. CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 21. U.S. CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 22. U.S. CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 23. CANADA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 24. CANADA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 25. CANADA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 26. MEXICO CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 27. MEXICO CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 28. MEXICO CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 29. EUROPE CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 30. EUROPE CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 31. EUROPE CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 32. EUROPE CELL CRYOPRESERVATION MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 33. GERMANY CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 34. GERMANY CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 35. GERMANY CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 36. FRANCE CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 37. FRANCE CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 38. FRANCE CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 39. UK CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 40. UK CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 41. UK CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 42. ITALY CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 43. ITALY CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 44. ITALY CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 45. SPAIN CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 46. SPAIN CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 47. SPAIN CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 48. REST OF EUROPE CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 49. REST OF EUROPE CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 50. REST OF EUROPE CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 51. ASIA-PACIFIC CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 52. ASIA-PACIFIC CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 53. ASIA-PACIFIC CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 54. ASIA-PACIFIC CELL CRYOPRESERVATION MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 55. JAPAN CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 56. JAPAN CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 57. JAPAN CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 58. CHINA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 59. CHINA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 60. CHINA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 61. INDIA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 62. INDIA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 63. INDIA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 64. AUSTRALIA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 65. AUSTRALIA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 66. AUSTRALIA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 67. SOUTH KOREA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 68. SOUTH KOREA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 69. SOUTH KOREA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 70. MALAYSIA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 71. MALAYSIA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 72. MALAYSIA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 73. REST OF ASIA-PACIFIC CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 74. REST OF ASIA-PACIFIC CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 75. REST OF ASIA-PACIFIC CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 76. LAMEA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 77. LAMEA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 78. LAMEA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 79. LAMEA CELL CRYOPRESERVATION MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 80. BRAZIL CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 81. BRAZIL CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 82. BRAZIL CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 83. SOUTH AFRICA, CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 84. SOUTH AFRICA, CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 85. SOUTH AFRICA, CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 86. SAUDI ARABIA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 87. SAUDI ARABIA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 88. SAUDI ARABIA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 89. REST OF LAMEA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 90. REST OF LAMEA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 91. REST OF LAMEA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 92. CREATIVE BIOLABS: KEY EXECUTIVES
TABLE 93. CREATIVE BIOLABS: COMPANY SNAPSHOT
TABLE 94. CREATIVE BIOLABS: PRODUCT SEGMENTS
TABLE 95. CREATIVE BIOLABS: SERVICE SEGMENTS
TABLE 96. CREATIVE BIOLABS: PRODUCT PORTFOLIO
TABLE 97. EPPENDORF CORPORATE: KEY EXECUTIVES
TABLE 98. EPPENDORF CORPORATE: COMPANY SNAPSHOT
TABLE 99. EPPENDORF CORPORATE: PRODUCT SEGMENTS
TABLE 100. EPPENDORF CORPORATE: PRODUCT PORTFOLIO
TABLE 101. EPPENDORF CORPORATE: KEY STRATERGIES
TABLE 102. LONZA: KEY EXECUTIVES
TABLE 103. LONZA: COMPANY SNAPSHOT
TABLE 104. LONZA: PRODUCT SEGMENTS
TABLE 105. LONZA: SERVICE SEGMENTS
TABLE 106. LONZA: PRODUCT PORTFOLIO
TABLE 107. PROMOCELL GMBH: KEY EXECUTIVES
TABLE 108. PROMOCELL GMBH: COMPANY SNAPSHOT
TABLE 109. PROMOCELL GMBH: PRODUCT SEGMENTS
TABLE 110. PROMOCELL GMBH: PRODUCT PORTFOLIO
TABLE 111. SARTORIUS AG: KEY EXECUTIVES
TABLE 112. SARTORIUS AG: COMPANY SNAPSHOT
TABLE 113. SARTORIUS AG: PRODUCT SEGMENTS
TABLE 114. SARTORIUS AG: PRODUCT PORTFOLIO
TABLE 115. BIOLIFE SOLUTIONS, INC.: KEY EXECUTIVES
TABLE 116. BIOLIFE SOLUTIONS, INC.: COMPANY SNAPSHOT
TABLE 117. BIOLIFE SOLUTIONS, INC.: PRODUCT SEGMENTS
TABLE 118. BIOLIFE SOLUTIONS, INC.: SERVICE SEGMENTS
TABLE 119. BIOLIFE SOLUTIONS, INC.: PRODUCT PORTFOLIO
TABLE 120. BIOLIFE SOLUTIONS, INC.: KEY STRATERGIES
TABLE 121. DANAHER CORPORATION: KEY EXECUTIVES
TABLE 122. DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 123. DANAHER CORPORATION: PRODUCT SEGMENTS
TABLE 124. DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 125. DANAHER CORPORATION: KEY STRATERGIES
TABLE 126. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
TABLE 127. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
TABLE 128. THERMO FISHER SCIENTIFIC INC.: PRODUCT SEGMENTS
TABLE 129. THERMO FISHER SCIENTIFIC INC.: SERVICE SEGMENTS
TABLE 130. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
TABLE 131. THERMO FISHER SCIENTIFIC INC.: KEY STRATERGIES
TABLE 132. HIMEDIA LABORATORIES: KEY EXECUTIVES
TABLE 133. HIMEDIA LABORATORIES: COMPANY SNAPSHOT
TABLE 134. HIMEDIA LABORATORIES: PRODUCT SEGMENTS
TABLE 135. HIMEDIA LABORATORIES: PRODUCT PORTFOLIO
TABLE 136. MERCK GROUP KGAA: KEY EXECUTIVES
TABLE 137. MERCK GROUP KGAA: COMPANY SNAPSHOT
TABLE 138. MERCK GROUP KGAA: PRODUCT SEGMENTS
TABLE 139. MERCK GROUP KGAA: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. CELL CRYOPRESERVATION MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF CELL CRYOPRESERVATION MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN CELL CRYOPRESERVATION MARKET (2023-2032)
FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 05. LOW THREAT OF NEW ENTRANTS
FIGURE 06. LOW THREAT OF SUBSTITUTES
FIGURE 07. LOW INTENSITY OF RIVALRY
FIGURE 08. LOW BARGAINING POWER OF BUYERS
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALCELL CRYOPRESERVATION MARKET
FIGURE 10. PATENT ANALYSIS BY COMPANY
FIGURE 11. PATENT ANALYSIS BY COUNTRY
FIGURE 11. CELL CRYOPRESERVATION MARKET, BY TYPE, 2022(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF CELL CRYOPRESERVATION MARKET FOR CRYOPRESERVATION MEDIA, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF CELL CRYOPRESERVATION MARKET FOR EQUIPMENT, BY COUNTRY 2022 AND 2032(%)
FIGURE 14. CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF CELL CRYOPRESERVATION MARKET FOR STEM CELLS, BY COUNTRY 2022 AND 2032(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF CELL CRYOPRESERVATION MARKET FOR OOCYTES CELLS, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF CELL CRYOPRESERVATION MARKET FOR SPERM CELLS, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF CELL CRYOPRESERVATION MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 19. CELL CRYOPRESERVATION MARKET, BY END USER, 2022(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF CELL CRYOPRESERVATION MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY, BY COUNTRY 2022 AND 2032(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF CELL CRYOPRESERVATION MARKET FOR RESEARCH INSTITUTE, BY COUNTRY 2022 AND 2032(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF CELL CRYOPRESERVATION MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 23. CELL CRYOPRESERVATION MARKET BY REGION, 2022
FIGURE 24. U.S. CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
FIGURE 25. CANADA CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
FIGURE 26. MEXICO CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
FIGURE 27. GERMANY CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
FIGURE 28. FRANCE CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
FIGURE 29. UK CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
FIGURE 30. ITALY CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
FIGURE 31. SPAIN CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
FIGURE 32. REST OF EUROPE CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
FIGURE 33. JAPAN CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
FIGURE 34. CHINA CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
FIGURE 35. INDIA CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
FIGURE 36. AUSTRALIA CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
FIGURE 37. SOUTH KOREA CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
FIGURE 38. MALAYSIA CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
FIGURE 39. REST OF ASIA-PACIFIC CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
FIGURE 40. BRAZIL CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
FIGURE 41. SOUTH AFRICA, CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
FIGURE 42. SAUDI ARABIA CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
FIGURE 43. REST OF LAMEA CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
FIGURE 44. TOP WINNING STRATEGIES, BY YEAR
FIGURE 45. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 46. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 47. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 48. COMPETITIVE DASHBOARD
FIGURE 49. COMPETITIVE HEATMAP: CELL CRYOPRESERVATION MARKET
FIGURE 50. TOP PLAYER POSITIONING, 2022
FIGURE 51. EPPENDORF CORPORATE: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 52. EPPENDORF CORPORATE: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 53. EPPENDORF CORPORATE: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 54. LONZA: NET SALES, 2020-2022 ($MILLION)
FIGURE 55. LONZA: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 56. LONZA: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 57. SARTORIUS AG: NET SALES, 2020-2022 ($MILLION)
FIGURE 58. SARTORIUS AG: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 59. SARTORIUS AG: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 60. BIOLIFE SOLUTIONS, INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 61. BIOLIFE SOLUTIONS, INC.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 62. DANAHER CORPORATION: NET SALES, 2020-2022 ($MILLION)
FIGURE 63. DANAHER CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 64. DANAHER CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 65. THERMO FISHER SCIENTIFIC INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 66. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 67. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 68. MERCK GROUP KGAA: NET SALES, 2020-2022 ($MILLION)
FIGURE 69. MERCK GROUP KGAA: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 70. MERCK GROUP KGAA: REVENUE SHARE BY REGION, 2022 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security